NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/23/2024
Back to search
Official data from USPTO
PRADAXA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
10/23/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
08/04/2003
Registration date
08/17/2004
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/23/2024
Last transaction
10/23/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Drawing code
1
Owner type
03
Owner location
Ingelheim am Rhein, DE
Examiner
THOMPSON, HEATHER
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Boehringer Ingelheim Pharma GmbH & Co. KG
Representatives
Max Moskowitz Ostrolenk Faber LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations and substances for the treatment of the alimentary tract and metabolismblood and blood forming organsthe cardiovascular systemthe musculoskeletal systemthe central nervous systemthe peripheral nervous systemthe genitourinary systemthe respiratory systemdermatological disorders; hormones for medical purposes; anti-infective preparations; anti-viral preparations; cytostatic preparations; allergy medication; nutrient dietary preparations adapted for medical purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/23/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/23/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
07/26/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/17/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/03/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/03/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/03/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/03/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
08/18/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/28/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/26/2011
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
11/19/2010
PAPER RECEIVED
11/19/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
08/17/2004
PUBO
PUBLISHED FOR OPPOSITION
05/25/2004
NPUB
NOTICE OF PUBLICATION
05/05/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2004
DOCK
ASSIGNED TO EXAMINER
03/22/2004
DOCK
ASSIGNED TO EXAMINER
03/05/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2004
PAPER RECEIVED
02/23/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2004
CNRT
NON-FINAL ACTION MAILED
02/05/2004
DOCK
ASSIGNED TO EXAMINER
02/03/2004
Continuous trademark protection
Get notified about every new filing that threatens PRADAXA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.